Consent is the area where the gap between what is required and what is practised is widest in this sector, and it is the area most likely to determine the outcome of a complaint.
The standard
Valid consent has three components. Capacity: the person is able to understand, retain, weigh and communicate a decision about this specific matter. Voluntariness: the decision is their own, free from pressure. And information: they have been given what they need to make it.
The information component is where UK law has moved most, and it has moved towards the patient. The test is oriented around what a reasonable person in the patient's position would be likely to attach significance to, and around what this particular patient would. That means risks that are statistically small can still be material if this person would care about them, which in cosmetic work they very often would.
What has to be covered
What the procedure involves, in terms the person understands. The material risks, including those specific to their anatomy and circumstances. What the realistic range of outcomes is, including the possibility that the result is not what they hoped. The reasonable alternatives, including doing nothing at all, which is always an alternative in elective cosmetic work and is frequently not presented as one. What happens if there is a complication, who manages it, and what it costs. Whether the effect is reversible, and by what means. And who will actually perform the procedure.
The alternative of doing nothing is the item most consistently omitted in this sector, and its absence is diagnostic. A consultation that never presents not proceeding as a legitimate option is not obtaining consent, it is closing a sale.
What the professional regulators expect
Professional guidance on consent applies to registered practitioners and is more demanding than the minimum. It addresses the practitioner's responsibility to make sure the person has understood rather than merely been told, to allow time for reflection, and to be alert to pressure including commercial pressure.
Guidance addressing cosmetic interventions specifically also deals with promotional practices, with two stage consultations, and with not making the offer of a procedure contingent on an immediate decision.
ObservedProfessional regulators publish guidance on consent and, in some cases, guidance addressing cosmetic interventions specifically. Both are published in full and are the authority for what is expected of registrants.AnalysisFor an unregistered practitioner, none of that professional guidance applies. The general law of consent still does, and so does consumer law, but there is no regulator to enforce a standard of process.Time, and why same day treatment is a problem
Nothing in general law prohibits treating on the day of the first consultation. Professional guidance in this area consistently expects that a person considering an elective cosmetic procedure has time to reflect, and that the process is not structured to produce an immediate decision.
A time limited discount conditioned on booking today is in direct tension with that expectation, which is why it attracts attention from both the advertising rules and professional standards. The commercial function of such an offer is to prevent reflection, which is precisely what consent requires.
What a form can and cannot do
A signed form is evidence that a conversation is said to have happened. It is not consent, and a signature does not cure a defective process. Consent obtained without capacity, without voluntariness or without material information is not made valid by documentation.
What good documentation does is record the process: what was discussed, which risks were covered, which alternatives including doing nothing were presented, what questions were asked and answered, and how much time passed between the discussion and the procedure. That record is what a regulator or a court will actually look at.
Two consents, routinely conflated
Consent to treatment and consent to use images in marketing are different things with different legal bases and different withdrawal implications. They must be obtained separately, and consent to publication must be specific and genuinely withdrawable.
Bundling them into a single form is common and it fails in both directions: it taints the treatment consent with a commercial condition, and it produces a publication consent that a patient can reasonably say they did not give freely.
Who should take consent, and when
Consent should be taken by the person performing the procedure, or by someone with sufficient knowledge of it to answer any question the patient might reasonably ask, including about the specific risks in this person's case.
In practice consent in this sector is frequently taken by a receptionist handing over a form, or by a treatment coordinator whose role is partly commercial. Both arrangements are problematic for the same reason: the person obtaining consent cannot answer the questions that make it informed, and in the second case has an interest in the answer.
Timing matters as much as personnel. Consent obtained immediately before a procedure, in a treatment room, with the patient already committed and often already paid, is structurally different from consent obtained at a separate consultation with time in between. Nothing prohibits the first arrangement. A great deal of professional guidance points away from it.
The failure patterns that produce complaints
Four recur, and they are recognisable in advance.
Risk discussed generically. A list of possible complications read out or printed, with nothing said about which are relevant to this person's anatomy, medical history or requested treatment. Generic risk information is a document, not a discussion.
The outcome oversold in the consultation and qualified only in the form. If the conversation promises more than the paperwork admits, the patient consented to the conversation. Courts and regulators look at what the person was actually led to believe.
Doing nothing never mentioned. Already covered above, and it is the single most common omission in this sector.
The person who treated was not the person who consented, and was not the person the patient expected. Who will perform the procedure is material information, and a substitution made on the day, however competent the substitute, undermines the consent that was given.
Age and capacity
In England, the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 makes it an offence to administer botulinum toxin or certain fillers to a person under 18 for a cosmetic purpose, and to make arrangements for that. Parental consent does not create an exception. Where age is in question, an age verification procedure must exist at the point of booking, not only at the point of treatment.
Capacity is a separate question from age and is assessed in relation to the specific decision at the specific time. It can be affected by circumstances that are temporary.